Biotechnology News

December 4, 2012

SAN DIEGO--(BUSINESS WIRE)--MedImpact now offers patient-focused specialty pharmacy management programs in hemophilia and multiple sclerosis designed for population management.

December 4, 2012

PALO ALTO, Calif.--(BUSINESS WIRE)--Dorsey & Whitney Adds Patent Veteran Scott Smith as Partner in Palo Alto Office

December 4, 2012

ALAMEDA, Calif.--(BUSINESS WIRE)--BioTime, Inc. (NYSE MKT: BTX), a biotechnology company that develops and markets products in the field of regenerative medicine, announced that Chief Executive Officer Michael D. West, Ph.D. will provide an...

December 4, 2012

PALO ALTO, Calif.--(BUSINESS WIRE)--Vascular Closure Systems, Inc. Announces the Completion of the First in Human (FIH) Clinical Trial of the 6 Fr. / 7 Fr. FastSeal® Bioabsorbable Vascular Access Closure System - 100% Successful Results

December 4, 2012

LARKSPUR, Calif.--(BUSINESS WIRE)--Bay-area based BioCision raises $2.5 million in growth financing.

December 4, 2012

PALO ALTO, Calif. & EMERYVILLE, Calif.--(BUSINESS WIRE)--Open Monoclonal Technology, Inc. (OMT) and Crystal Bioscience, Inc. (Crystal) today announced a strategic alliance where OMT will access Crystal’s deep antibody screening technology,...

December 4, 2012

DURHAM, N.C.--(BUSINESS WIRE)--Cenduit LLC has introduced a new study simulation and forecasting service that will enable clinical trial sites to better plan and control supplies for their patients.

December 4, 2012

BURLINGTON, Mass.--(BUSINESS WIRE)--Decision Resources, one of the world’s leading research and advisory firms for pharmaceutical and healthcare issues, finds that the entry of seven new agents into the Non-Small-Cell Lung Cancer (NSCLC) drug...

December 4, 2012

GÖTEBORG, Sweden--(BUSINESS WIRE)--Regulatory News: Global Health Partner (STO:GHP) today won the “Best Annual Report 2011” prize. The prize is awarded by NASDAQ OMX and GHP won in the Small Cap category. NASDAQ OMX’s citation for the prize was...

December 4, 2012

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--A survey of US drug companies found that 88% have market access teams actively involved in Phase 2 trials, according to Cutting Edge Information.

December 4, 2012

BERLIN--(BUSINESS WIRE)--NOXXON Pharma announces the treatment of the first patients in a Phase IIa clinical trial of its anti-hepcidin Spiegelmer® NOX-H94 to treat anemia associated with chronic disease.

December 4, 2012

CONCORD, Calif.--(BUSINESS WIRE)--Cerus has signed a 2-year purchase agreement with two regional Swiss Red Cross Blood Services for deployment of the INTERCEPT Blood System for plasma.

December 4, 2012

SAN DIEGO--(BUSINESS WIRE)--Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) will be providing a detailed review of its business model and growth strategy, along with introducing financial guidance for 2013 and 2014, during its Analyst Day...

December 4, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--New Clinical Data Highlighting Foundation Medicine’s Next-Generation Sequencing Analysis in Breast Cancer to be Presented at SABCS

December 4, 2012

MALVERN, Pa.--(BUSINESS WIRE)--PhaseBio Pharmaceuticals, Inc, a privately held, clinical-stage biotechnology company developing novel drugs to treat metabolic and cardiovascular diseases, announced today that Jonathan P. Mow has been appointed...

December 4, 2012

BURLINGTON, Mass. & BICESTER, England--(BUSINESS WIRE)--Decision Resources Group, one of the world’s leading research and advisory firms focusing on healthcare insights and analysis, announced today that it acquired Abacus International, a...

December 4, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--VSTM management to present at OPCO healthcare conference 12/13/12

December 4, 2012

WATERTOWN, Mass.--(BUSINESS WIRE)--Arsenal Medical Inc. presented dramatic progress in the development of high-throughput electrospinning technology Thursday, November 8, 2012, at the Fall Meeting of The Fiber Society in Boston, Mass.

December 4, 2012

COLOGNE, Germany--(BUSINESS WIRE)--Axiogenesis earned a US patent for invention of an in vitro disease model using stem cell-derived cardiomyocytes to evaluate drug candidates and molecular targets for Hypertrophic Cardiomyopathy (HCM)

December 4, 2012

BEND, Ore.--(BUSINESS WIRE)--Agere Pharmaceuticals Inc, a leading oral bioavailability CRO/CMO, announced today that it has added Regulatory Guidance to the breadth of services.

December 4, 2012

DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX) has entered into a definitive agreement to acquire Gambro AB, a privately held dialysis product company based in Lund, Sweden, for total consideration of 26.5 billion SEK (...

December 4, 2012

MIAMI--(BUSINESS WIRE)--Speaking today at the American Association of Cancer Research Special Conference on Tumor Immunology in Miami, Florida, Dr. Ofer Levy, Senior Scientist at Compugen Ltd., presented data supporting the therapeutic potential...

December 4, 2012

BELLEVUE, Wash. & MENLO PARK, Calif.--(BUSINESS WIRE)--Kona Medical, developer of non-invasive renal denervation for hypertension, completed $40 million Series C round. Two large-cap companies joined leading venture investors in the financing...

December 4, 2012

NEWARK, Del.--(BUSINESS WIRE)--Next Generation Anthrax Vaccines contract awarded to Fraunhofer USA Center for Molecular Biotechnology

December 4, 2012

MILAN, Italy--(BUSINESS WIRE)--Sorin receives Japanese Pharmaceuticals and Medical Devices Agency (PMDA) approval for the Mitroflow® Aortic Pericardial Heart Valve.

December 3, 2012

DUBLIN--(BUSINESS WIRE)--ICON plc provides 2013 Financial Guidance ahead of Investor Day in New York

December 3, 2012

WALTHAM, Mass.--(BUSINESS WIRE)--Avedro expands its corneal cross-linking research team

December 3, 2012

SEATTLE & SAN ANTONIO, Texas--(BUSINESS WIRE)--NanoString today announced that results from three studies of its breast cancer assay based on the PAM50 gene expression signature will be presented at the San Antonio Breast Cancer Symposium

December 3, 2012

NEW YORK--(BUSINESS WIRE)--Forest Laboratories, Inc. (NYSE: FRX) today announced it will be presenting data on cariprazine at the American College of Neuropsychopharmacology Annual Meeting scheduled December 2-6, 2012 in Hollywood, FL. Forest...

December 3, 2012

NEW YORK--(BUSINESS WIRE)--Deerfield Management appoints Jonathan S. Leff as a Partner of Deerfield Management and Chairman of the Deerfield Institute.

December 3, 2012

FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) announced today that the company will be webcasting its corporate presentation at the NASDAQ OMX 29th Investor Program in London. Kevin Young CBE, Gilead’s Executive Vice...

December 3, 2012

TORONTO--(BUSINESS WIRE)--SQI Diagnostics to Extend Warrant Expiry Date

December 3, 2012

SANTA CLARA, Calif.--(BUSINESS WIRE)--Affymetrix, Inc., (NASDAQ: AFFX) today has given notice of its intention to redeem all of the outstanding 3.50% Senior Convertible Notes due 2038 (CUSIP 00826TAG3) (the “Convertible Notes”) on January 15,...

December 3, 2012

LOS ANGELES--(BUSINESS WIRE)--ImmunoCellular Therapeutics, Ltd. (“ImmunoCellular”) (NYSE MKT: IMUC) announced today the appointment of Andrew Gengos as President and Chief Executive Officer and member of the Board of Directors. With more than 20...

December 3, 2012

MOUNTLAKE TERRACE, Wash.--(BUSINESS WIRE)--NEW! Version 7.0 of Freezerworks Basic. An upgrade that makes things a whole lot easier!

December 3, 2012

MIDLAND, Mich.--(BUSINESS WIRE)--Dow Performance Packaging, a business unit of The Dow Chemical Company, announced it has reached a new innovation milestone by creating 42 new products for the high performance packaging sector.

December 3, 2012

BILLERICA, Mass.--(BUSINESS WIRE)--The Scientist magazine placed EMD Millipore’s CellASIC™ ONIX Microfluidic Platform in 6th place in its annual Top 10 Innovations contest

December 3, 2012

FORT LAUDERDALE, Fla.--(BUSINESS WIRE)--Dr. Verne A. Luckow has joined the law firm of Roetzel & Andress in Fort Lauderdale, Florida, as Senior Counsel in the Intellectual Property Group.

December 3, 2012

MIDLAND, Mich.--(BUSINESS WIRE)--Fueled by robust investments in global plant breeding programs, Dow AgroSciences, has captured a greater share of the North and South American corn seed market.

December 3, 2012

FARGO, N.D. & SUNNYVALE, Calif.--(BUSINESS WIRE)--Altravax, Inc. announced today that it has been awarded two research grants worth a total of $3.45 million from NIAID (NIH) for research on antibody-inducing vaccines for HIV-1

December 3, 2012

MIDLAND, Mich.--(BUSINESS WIRE)--At its 2012 Investor Forum, The Dow Chemical Company (NYSE: DOW) today reinforced the Company’s commitment to its long-term strategy.

December 3, 2012

NEW YORK--(BUSINESS WIRE)--NYU Langone Medical Center announced that it plans a phased re-opening of its main clinical facility, Tisch Hospital, prior to the end of December and a return of nearly all services to the medical center by the end of...

December 3, 2012

PARIS & LAUSANNE, Switzerland--(BUSINESS WIRE)--Regulatory News: Ipsen (Euronext: IPN, ADR: IPSEY), a global specialty-driven pharmaceutical group, and Galderma, a leading global pharmaceutical company focused on dermatology, today announced...

December 3, 2012

ANN ARBOR, Mich.--(BUSINESS WIRE)--Online Tech 1st Hosting Provider Audited to Civil Rights HIPAA Audit Protocol

December 3, 2012

BOCA RATON, Fla.--(BUSINESS WIRE)--Akron Biotechnology, LLC’s Quality Management System was registered on November 30th, 2012 on the requirements of ISO 9001:2008 standards by BSI Group America Inc. This ISO Certification emphasizes Akron Biotech...

December 3, 2012

MEMPHIS, Tenn.--(BUSINESS WIRE)--Active Implants Corporation (AIC) has appointed international med-tech veteran Lex R. Giltaij, MD MBA as President and Chief Operating Officer. The Company also announced the establishment of its subsidiary’s...

December 3, 2012

BEDMINSTER, N.J.--(BUSINESS WIRE)--Cegedim Relationship Management today announced the release of its thought leadership report, 2012 US Pharma Insights, which provides the results of its third annual survey of life sciences decision makers on...

December 3, 2012

CHARLEROI, Belgium--(BUSINESS WIRE)--Delphi Genetics SA announced that the first antibiotic-free DNA vaccine using the Staby® technology was efficiently tested in vivo.